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ABSTRACT 
Aqueous extract bark of Anthocleista schweinfurthii (ASE) was investigated for anti-arthritic, anti-inflammatory activities and 
phytochemicals screening. Phytochemical screening was carried out according, to LC-MS procedures, the anti-inflammatory effect of ASE 
was evaluated in vitro inhibition of 15-lipoxygenase (15-LOX) enzyme and  proteinase inhibiting action assays. The anti-arthritic activity was 
performed according to the Bovine Serum Albumin (BSA) test. The chemical composition of ASE showed that it was mainly composed of 
isocyanate, biphenyltriol, methoxyflavanone, soscoparin and glucopyroside. In the anti-inflammatory assays, ASE showed selective 
inhibition of 15-lipooxygenase with IC50 value of                     and moderate activity against the inhibition of proteinase action with 
IC50 value of                   L. Both the methods  showed that the ASE posses good anti-inflammatory activity. ASE had strong in vitro 
anti-arthritic activity with IC50 of                   , the positive control Diclofenac had IC50 value of                    The result of this 
study justified the use of this plant in traditional Cameroonian medicine in the treatment of inflammation. ASE may offer a new source of 
potential therapeutic agents for the effective treatment of arthritis and inflammation.   
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INTRODUCTION 
Inflammation is a defense response of our body which 
involves a complex reaction of vascularised tissues to 
infection, allergens, toxin exposure and cell injury1,2. 
Conversely, uncontrolled inflammatory response is the 
main cause of a vast and continuous disorders inclusing 
cancer, septic shock, diabetes, atherosclerosis, obesity, 
heart disease, age-related muscular degeneration, chronic 
obstructive pulmonary disease, multiple sclerosis, arthritis, 
rheumatoid arthritis 3,4,5.   
Rheumatoid arthritis is a chronic, systematic inflammatory 
disease predominanatly affecting the joints and peri-
articular tissues6. Currently, steroid drugs, non steroidal 
anti-inflammatory drugs (NSAIDs) and immuno-
suppressants, usually used for the relief of inflammatory 
diseases, require long-term treatment and their use is 
often associated with serious side effects such as bleeding, 
gastrointestinal and peptic ulcers7. Hence, continuous 
search for the development of potent anti-inflammatory 
drugs with fewer side effects is necessary from medicinal 
plants. 
A. schweinfurthii is a plant of the Loganiaceae family, it is a 
source of traditional recipe for the treatment of male and 
female fertility problems in Togo, Nigeria, Cameroon, 
Gabon and Equatorial Guinea8. The decoction of the bark of 
A. schweinfurthii is used for the treatment of sexually 
transmitted infections9. A decoction of barks of root and 
leaves of A. schweinfurthii in Tanzania, is used for the 
treatment of malaria. A decoction of bark and leaves of A. 
schweinfurthii is used in Tanzania for the treatment of pain, 
injury and inflammatory diseases9,10. In Cameroon, Gabon, 
Equatorial Guinea, Congo, and Tanzania, a decoction of A. 
schweinfurthii bark is used for the treatment of microbial 
infections and bronchitis11. In Congo, the decoction of bark 
of A. schweinfurthii is used to treat hernia12. In Nigeria, A. 
djalonensis is used in traditional medicine to treat breast 
cancer13. In Cameroon, the decoction of bark of A. 
schweinfurthii co  only known as “Bopolopolo” in the 
Douala language is used for the treatment of 
gastrointestinal disorders, gastric ulcers, abdominal pain, 
A. schweinfurthii is used for its galactogenic properties9,14. 
The in vitro antioxidant activity, cytotoxicity and 
genotoxicity of extracts from the leaves and barks of A. 
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schweinfurthii have been already done15. Djeussi et al16. 
evaluated the antibacterial properties of the methanol 
extract of A. schweinfurthii; the vasoconstrictor and 
inotropic effects induced by the root bark extracts 
of A. schweinfurthii was investigated by Ngombe et al17. A 
new steroid, schweinfurthiin, two known compounds, 
bauerenone, bauerenol and xanthones were isolated in the 
dichloomethane/methanol extract of the roots of A. 
schweinfurthii by Mbouangouere et al18. The acute and 
subacute toxicity of the aqueous extract of A. schweinfurthii 
bark was investigated by Christophe et al9. However, as far 
as known, no work has been devoted to the study of the 
anti-arthritic and anti-inflammatory activities of aqueous 
extracts of A. schweinfurthii. Therefore, the aim of the 
present study was to evaluate the anti-arthritic and the 
anti-inflammatory activities of aqueous extract powder 
barks of Anthocleista schweinfurthii Gild (Loganiaceae) . 
MATERIALS AND METHODS 
Plant material and extraction procedure 
A. schweinfurthii plant was collected at Loum in the Littoral 
region of Cameroon in August 2016, it is commonly known 
in Ca eroon as “Betbreu” in Medumba local language and 
“Bopolopolo” in Douala local language. The plant 
identification was done at the Cameroon National 
Herbarium by comparison with specimen number 
52349/HNC of A. schweinfurthii Gild (Loganiaceae). 
The barks of A. schweinfurthii were air-dried for one week 
at room temperature and weighed. The sample were then 
ground to fine powder in a mortar and 500 g of dried 
powder was soaked for 48 hours in water. The mixing was 
filtered through Whatman No. 1 filter paper and 
lyophilized using the lyophilizator Biobase. Then, the 
aqueous extracts of A. schweinfurthii was collected in 
Eppendorf tubes and preserved in a refrigerator at 4 °C for 
further use. 
LC-MS procedures 
LS-MS analysis of OSE was carried out following a modified 
method of Abay et al19. High resolution mass spectra were 
obtained with an OTOF Spectrometer (Bruker, Germany) 
equipped with a HESI source. The spectrometer was 
operated in positive mode (mass range: 100-1000, with a 
scan rate of 1.00 Hz) with automatic gain control to 
provide high-accuracy mass measurements within 2 ppm 
deviation using Na Formate as calibrant. The spectrometer 
was attached to an Ultimate 3000 (Thermo Fisher, USA) 
HPLC system consisting of LC-pump, Diode Array Detector 
(DAD) (λ =     n ), auto sa pler (injection volu e   L). 
MS analyses were performed in multiple reaction 
monitoring (MRM) mode by measuring the fragmentation 
products of the protonated pseudomolecular ions of COC, 
BE and EME and their internal standards in three different 
fragmentation windows. The ESI voltage was set at 4.5 kV. 
Parameters were optimised by injection of known amounts 
of the extract and evaluating retention times, analyte 
response, peak widths and shapes. C18 reversed-phase 
column oven (30°C) was used. The isocratic mobile phase 
was made up of two solvents water/AcN at different 
concentration water/AcN 95:5 and water/AcN 90:10. The 
starting eluent was used for equilibration of the column. 
Nitrogen was used as nebulising gas at a pressure of 40 psi. 
Dry gas debit was set at 8 L/min and capillary temperature 
at 200 °C. 
 
Anti-inflammatory assays 
Inhibition of 15-lipoxygenase (15-LOX) enzyme assay 
The assay was performed according to a previously 
described procedure by Pinto et al20 and Delong et al21 
with slight modifications. The assay measures the 
Fe3+/xylenol orange complex at 560 nm formed when the 
extract reacts with the assay reagents. Briefly, 15-LOX from 
Glycine max was incubated with compounds or standard 
inhibitor at 25 °C for 5 min. Then linoleic acid (final 
concentration, 140 mM) in Tris-HCl buffer (50 mM, pH 7.4) 
was added and the mixture was incubated at 25 °C for an 
additional 20 min in the dark. The reaction was terminated 
by the addition of 100 mL of FOX reagent consisting of 
sulphuric acid (30 mM), xylenol orange (100 mM), iron (II) 
sulphate (100 mM) in methanol/water (9:1). For the 
control, only LOX solution and buffer were pipetted into 
the wells. Blanks contained the enzyme LOX during 
incubation, but the substrate (linoleic acid) was added 
after the FOX reagent. The LOX inhibitory activity was 
evaluated by calculating the percentage of the inhibition of 
hydroperoxide production from the changes in absorbance 
values at 560 nm after 30 min at 25 °C. 
% inhibition = ((Acontrol – Ablank) – (Asample – Ablank)/(Acontrol – 
Ablank)) x100 
Where, Acontrol is the absorbance of control well, Ablank is the 
absorbance of blank well and Asample is the absorbance of 
sample well.  
Proteinase Inhibitory Action  
The anti-proteinase activity of ASE was determined using 
the method of Oyedepo et al22 with slight modifications. 
The reaction mixture (2 mL) was containing 0.06 mg 
trypsin, 1 mL of 20 mM Tris HCl buffer (pH 7.4) and 1 mL 
test sample of different concentrations. The reaction 
mixture was incubated at 37 °C for 5 min and then 1 mL of 
5 % (W/V) casein was added. The mixture was incubated 
for an additional 20 min, 2 mL of 70 % perchloric acid was 
added to terminate the reaction. Cloudy suspension was 
centrifuged and the absorbance of the supernatant was 
read at 210 nm against buffer as blank. The experiment 
was performed in triplicate. The percentage of inhibition of 
proteinase inhibitory activity was calculated.       
Anti-arthritic assay 
Bovine Serum Albumin (BSA) denaturation assay 
Protein denaturation was performed as described by Sakat 
et al23 with slight modifications. The test solution 
consisting of 1 mL of different concentrations of extracts 
preparation ranging from 0.5 to 1.5 mg/mL or standard 
Diclofenac sodium 0.1 and 0.25 mg/mL was mixed with 1 
mL of egg albumin solution (1 mM) and incubated at 27 ± 1 
°C for 15 min. Denaturation was induced by keeping the 
reaction mixture at 70 °C in a water bath for 10 min. After 
cooling, the turbidity was measured using the Jenway 6305 
spectrophotometer at 660 nm. Percentage inhibition of 
denaturation was calculated from control where no drug 
was added. Each experiment was done in triplicate. 
Statistical analysis 
The results are presented as means of three experiments. 
Statistical significance between groups was calculated by 
using a paired t-test with GraphPad Prism software 
(version 7). Values were expressed as mean ± SD and 
differences were considered significant statistically if 
P˂0.05.
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RESULTS  
          Figure 1 resumes the number of phytoconstituents present in the extract by comparing with the blank. 
 
Figure 1: LC-MS chromatogram obtained from ASE 
           
The compounds constituting the ASE were identified 
through interpretation of their mass spectrum obtained by 
LC/MC in comparison with previously reported data from 
the literature. The compounds were identified from their 
protonated molecular ion [M] +. The figure 1 shown that 
ASE exhibited presence of compound 2 to compound 25. 
The compounds with high amount were also identified in 
the case of this study. The compound 3 exhibited a pseudo-
molecular ion peak at m/z 239,067 [M+H+]+ in the 
HRESIMS corresponding to the molecular formula of  
C11H6N6O and retention time of 1.3 min, compound 3 was 
identified as 3-Isocyanato-8-(4-pyridinyl)[1,2,4]triazolo 
[4,3-b] pyridazin. The compound 4 had a pseudo-
molecular ion peak at m/z 203.06 [M+H+]+ in the HRESIMS 
corresponding to the molecular formula of C12H10O3 with 
retention time of 1.8 min, identified as biphenyltriol. The 
compound 8 showed a pseudo-molecular ion peak at m/z 
302.0874 [M+Na+]+ in the HRESIMS corresponding to the 
molecular formula of C16H1406 and retention time of 3.3 
min, the compound 8 was identified as 3',5,7-Trihydroxy-
4'-methoxyflavanone. The compound 13 had a pseudo-
molecular ion peak of m/z 362.3123 [M+Na+]+ in the 
HESIMS corresponding to the molecular formula of 
C21H38N4O with retention time of 5.1 min, was identified as 
8-[1-(1-Azepanyl)-2-propanyl]-2-(3-methylbutyl)-1,3,8-
triazaspiro[4.5]dec-1-en-4-one. The compound 17 showed 
a pseudo-molecular formula ion peak at m/z 302.0874 
[M+Na+]+ in the HRESIMS corresponding to the molecular 
formula of C21H20O10 and retention time of 5.9, the 
compound 17 was identified as 3,8-Dihydroxy-6-methyl-
9,10-dioxo- 9,10-dihydro-1-anthracenyl beta-D-gluco 
pyranoside. The last one, the compound 20 exhibited a 
pseudo-molecular formula ion peak at m/z 463,12 
[M+Na+]+ in the HRESIMS corresponding to the molecular 
formula of C22H22O11 with retention time of 6.4 was 
identified as soscoparin. 
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Compound 4 
                                 
biphenyltriol 
Compound 8 
                                                 
3',5,7-Trihydroxy-4'-methoxyflavanone               
Compound 13 
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Compound 20 
 
Soscoparin          
 
Anti-inflammatory activity 
Ferrous oxidation-xylenol orange (Fox) assay 
Inhibition of 15-lipoxygenase by ASE using in vitro 15-Lox enzyme assay showed average inhibition of 15-Lox with IC50 value 
of                   while the standard Quercetin with IC50 value of 6.71 0.1931        which is shown in figures 2 and 3 
 
Figure 2: % of Inhibition of the 15-lipoxygenase activity of ASE and Quercetin at different concentrations from which IC50 
values of OSE and Quercetin was obtained. Values are mean ± SD of three experiments. 
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Figure 3: Comparison of IC50 of ASE with Quercetin. Data are expressed as mean ±SD, Quercetin was used as a reference 
compound. Statistical differences between quercetin and ASE as analyzed by the paired t-test  (****P˂      )  
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Proteinase Inhibitory Action  
The ASE showed moderate inhibition of proteinase action with IC50 value of 244.33 2.08 µg/mL whereas for Aspirin, a 
standard drug had IC50 value of 53.79   2.61 µg/mL (figure’s 4 and 5). 
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Figure 4: % of Inhibition of the proteinase action of ASE and Aspirin at different concentrations from which IC50 values of 
ASE and Aspirin was obtained. Values are mean ±SD of three experiments. 
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Figure 5: Comparison of IC50 of ASE with Aspirin. Data are expressed as mean ±SD, Aspirin was used as a standard drug. 
Statistical differences between Aspirin and ASE as analyzed by the paired t-test (***P˂      )  
Anti-arthritic activity 
The anti-denaturation study for investigating anti-arthritis activity was ascertained in this study using Bovine Serum 
Albumin (BSA) assay. The ASE displayed a strong inhibition activity of Bovine Serum Albumine denaturation with IC50 value 
of                  as compared with that of the standard drug Diclofenac with IC50 value of                . The results 
were illustrated by the figures 6 and 7. 
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Figure 6: % of Inhibition of the protein denaturation activity of ASE and Diclofenac sodium at different concentrations from 
which IC50 value of ASE and Diclofenac sodium was obtained. The error bars represent the standard deviation of 
measurement of the absorbance, experiment was done in triplicate. 
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Figure 7: Comparison of IC50 of ASE with diclofenac sodium. Data are expressed as mean ±SD, Diclofenac sodium was used as 
a standard drug. Statistical differences between Diclofenac sodium and ASE as analyzed by the paired t-test (****P˂      )  
 
DISCUSSION 
We reported the identification of isocyanate, Soscoparin, 
biphenyltriol, methoxy-flavone, glycoside and flavonoids in 
the ASE. This result confirms literature review which 
revealed that Antocleista genus is a rich source of 
biocompounds such as alkaloids, xanthone, scoiridoids, 
and terpene24, contradicting in other hands to some author 
who reported that reducing sugar and glycosides were 
found to be absent in both the leaf and the stem-bark of the 
Anthocleista species25,26. Inflammation is induced by 
several pathway, one of the most pathway, it is initiated by 
the action of lipoxygenase on arachidonic acid producing 
trioxilins and leukotriene29. Agent which possess the 
ability of inibition of the 15-Lipoxygenase could be used as 
a potent anti-inflammatory agent. The anti-inflammatory 
effect was ascertained in this study by the inhibition of 15-
lipoxygenase and proteinase inhibition assays. Statistically 
(****P˂      ) ASE showed selective inhibition of 15-
lipooxygenase compared with that of the standard 
Quercetin. Proteinases have been implicated in arthritic 
reactions, it was previously reported that proteinase plays 
an important role in the development of tissue damage 
during in inflammatory reactions and significant level of 
protection was provided by proteinase inhibitors30. The 
present investigation has shown that, ASE had moderate 
proteinase inhibition action, statistically significant 
(****P˂      ) compared with that of the standard drug, 
Aspirin. There are several inflammatory study showing 
anti-inflammatory activity of the different parts of 
Anthocleista species. Analgesic properties of A. vogeli stem 
barks has been reported by Mbiantcha et al31, Baba and 
Usifoh32 showed that the ethanol-water extract of A. 
djalonensis root revealed significant anti-inflammatory 
activity. The anti-lipoxygenase activity of ASE may be 
linked to the presence of biomolecules such as flavonoids, 
alkaloids and terpenes33. Flavonoids are known to 
interfere with the different stages of the arachidonate 
cascade via cyclooxygenase or lipoxygenase pathways to 
alleviate inflammatory responses34. Protein denaturation is 
one of the key features of inflammatory tissue and it 
undergoes denaturation and antigens are expressed which 
are associated with type-III hypersensitivity reaction, 
which in turn is related to diseases such as serum sickness, 
glomerulonephritis, rheumatoid arthritis and systemic 
lupus erythematosus4,27,35. Mecanism of denaturation 
probably involves alterations in electrostatic, hydrogen, 
hydrophobic and disulphide bonding34. It is believed that 
agent that can help in anti-protein denaturation could be 
used as a potent anti-inflammatory drug in future28. The 
anti-denaturation study for investigating anti-arthritis 
activity was ascertained in this study using BSA assay. ASE 
had showed a strong in vitro anti-arthritic activity 
statistically significant (***P˂      ) as compared with that 
of the standard drug Diclofenac. These findings support the 
traditional use of Anthocleista shweinfurthii as anti-
arthritic and in treatement of inflammatory disease in 
Cameroon. 
CONCLUSION 
Aqueous extracts of the bark of A. schweinfurthii was 
evaluated for their anti-arthritic and anti-inflammatory 
activities and their phytochemical study. The findings 
confirm the ethno medicinal use of A. schweinfurthii to 
manage the inflammation condition and arthritic. 
Isocyanate, biphenyltriol, methoxyflavanone, soscoparin 
and glucopyroside were identified in ASE. The isolation 
and characterization of these biomolecules and the 
understanding of the therapeutic targets of ASE will in the 
future allow the development of potential anti-
inflammatory agents from A. schweinfurthii bark. 
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